Back to dashboard
All PlansAdministrativeMedium impact

New tip sheet available for the Behavioral Health HEDIS measure: Follow-Up Care for Children Prescribed ADHD Medication (ADD)

UPMC Health Plan·Pediatrics, Family Medicine, Psychiatry·Pharmacy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply
—

Summary

A new tip sheet is available for the HEDIS ADD measure, which requires children aged 6-12 newly prescribed ADHD medications to have at least three appointments (initial prescriber visit plus follow-ups with treatment team including behavioral health providers) within 10 months of starting medication.

Action Required

Action needed
Immediately: Review the new HEDIS ADD tip sheet to understand continuity of care requirements for pediatric ADHD patients. Providers should ensure scheduling protocols include follow-up appointments with behavioral health treatment providers within 10 months for children 6-12 years old newly prescribed ADHD medications to meet quality measure requirements.

Related policy hubs